site logo
Last modified: 2018-02-21 10:49:12

Prochimia Surfaces is a part of the EVO-NANO project (Evolvable platform for programmable nanoparticle-based cancer therapies.) granted by the EU Horizon 2020 research and innovation programme!!!!

EVO-NANO gathers six research partners and one industrial with complementary expertise:University of Novi Sad, Faculty of Agriculture, Novi Sad, Serbia; University of the West of England, The Unconventional Computing Group, Bristol, UK; Department of Engineering Mathematics, Bristol Robotics Laboratory, Life Sciences, University of Bristol, Bristol, UK; Åbo Akademi University, Åbo, Finland; IMDEA Nanosciencia, Madrid, Spain; Vall d'Hebron Research Institute, Barcelona, Spain and ProChimia Surfaces, Sopot, Poland.

EVO-NANO is organized around two research hubs: computing sciences and modelling (PFNS, UB, UWE and AAU) and experimental in vitro and in vivo cancer and nanoparticle research (IMDEA, VHIR and PCS). Partners with cross-disciplinary expertise are expected to work between these hubs to produce an integrated synthesis between in silico models and their material realizations.

Our targeted scientific breakthrough is to establish, for the first time, an integrated evolvable platform for artificial evolution of novel NP-based drug delivery systems, their synthesis and rapid testing both in vivo and in vitro on a newly developed microfluidic-based platform.

Go back